Alnylam Pharmaceuticals, Inc. (ALNY) Social Stream



Alnylam Pharmaceuticals, Inc. (ALNY): $233.85

4.46 (+1.94%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ALNY to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

Alnylam Pharmaceuticals Inc (ALNY) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ALNY.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-19 17 $275 $108 $200 $162.43 23.13%
2021-11-22 18 $275 $108 $200 $162.43 23.13%
2021-12-29 19 $275 $108 $202.5 $162.43 24.67%
2022-01-11 19 $275 $108 $203.85 $162.43 25.5%
2022-01-18 19 $275 $108 $203.3 $162.43 25.16%
2022-01-23 19 $350 $108 $208.3 $162.43 28.24%
2022-01-28 18 $350 $108 $208.2 $162.43 28.18%
2022-02-10 18 $350 $109 $208.65 $162.43 28.46%
2022-02-14 16 $350 $103 $212.052 $162.43 30.55%
2022-02-22 16 $350 $103 $214.166 $162.43 31.85%
2022-03-10 16 $350 $103 $214.631 $162.43 32.14%

The Trend in the Analyst Price Target


Over the past 39 weeks, ALNY's average price target has gone up $39.85.

ALNY reports an average of 18.84% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 22 235 90 175.11 136.72 28.08%
2021-07-17 22 235 91 175.83 177.54 -0.96%
2021-08-05 22 235 93 180.68 193.90 -6.82%
2021-09-04 22 250 93 183.79 197.46 -6.92%
2021-12-29 19 275 108 202.50 170.08 19.06%

ALNY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.41 11 3 2 0 0 16

The Trend in the Broker Recommendations


ALNY's average broker recommendation rating improved by 0.88 over the prior 30 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ALNY as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, Alnylam Pharmaceuticals Inc's variance in analysts' estimates is lower than -1378.95% of them.
  • Alnylam Pharmaceuticals Inc's number of analysts covering the stock is higher than 1534.1% of Pharmaceutical Products stocks.
  • In terms of how Alnylam Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 1507.76% of that group.
  • ALNY has a greater upside potential (average analyst target price relative to current price) than 203.1% of Pharmaceutical Products stocks.

Stocks similar to Alnylam Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ALKS, ABCL, and VIR.

Is ALNY a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5968 seconds.